This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

  • Person examining data on tablet screen

    Latest Article

    How low should we go? Optimal blood pressure targets for people with type 2 diabetes to reduce kidney and cardiovascular outcomes

    The World Health Organization (WHO) has recognised that kidney disease will be one the top five preventable causes of death by the year 2050, placing a focus...

  • Man using home blood pressure monitor

    Blood pressure levels and outcomes in type 2 diabetes

  • Hospital laboratory worker

    Efficacy and safety of endothelin receptor antagonists in CKD: a meta‑analysis

  • Representation of human anatomy with kidneys

    TRPC6 inhibition in FSGS: a phase 2 trial of BI 764198

  • Concept of doctors networking.

    A challenge for 2026 and beyond in cardiorenal medicine

  • Multichannel pipette device for pharmaceutical research.

    Highlights of 2025: IgA nephropathy – an embarrassment of therapeutic riches

  • Pharmacist at work

    Highlights of 2025: the rise of finerenone

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe